Inamed pipeline balloons
This article was originally published in The Gray Sheet
Cohesive Silicone Gel Matrix breast implant application will be submitted to FDA in mid-2004, firm says. Inamed also is in talks with the agency concerning a regulatory pathway and late 2004 launch of a "ribbed" version of its Lap-band laparoscopic adjustable gastric band for morbid obesity. The company will decide by year-end whether to commence trials of an Intragastric Balloon, approved in Europe for temporary weight loss in obese patients...
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.